New coagulant bypasses clotting dysfunction in hemophilia.
Morrow
Thomas
T
Genentech, Inc.
D005167:Factor VII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D014481:United States
D005167:Factor VII